Important safety informationiDose TR is gently placed directly inside your eye by your eye doctor. You should not have iDose TR if you have an infection or suspected...
iDose® TR
iDose TR (travoprost intracameral implant) is an FDA-approved treatment that continuously releases medication to lower eye pressure.
Discover iDose TR, an FDA-endorsed medication.
iDose TR is tiny. It is 200 times smaller than a single drop of glaucoma medication.
iDose TR—the convenient way to help lower eye pressure
How it Works
Continuously releases medication exactly where you need it, inside the eye, to reduce pressure, protect vision, and ensure you get the medication you need all day and night.
Safe and effective
iDose TR was proven safe and effective in two large clinical studies of 1,150 patients with glaucoma. Most of the common side effects of iDose TR were mild.
Reduces drop side effects
In the iDose TR clinical studies, most patients did not experience any serious side effects. The most common side effects in the eye occured in only 2 to 6% of patients who received iDose TR.
What to expect with the iDose TR procedure
iDose TR is placed directly inside your eye through a tiny incision.
For most people, the procedure is painless and performed in an outpatient setting.
iDose TR starts working immediately to help keep your eye pressure under control.
Benefits of iDose TR
Continuously releases medication inside the eye.
Convenient alternative to prescription eye drops.
Reduces many of the side effects associated with prescription eye drops.
In a clinical study, 8 out 10 patients did not need prescription eye drops 12 months after administration of iDose TR.
